Mark Cuban calls Yusimry’s availability on MCCPDC ‘a game changer’
Mark Cuban Cost Plus Drug Company (MCCPDC) announced it is working with Coherus Biosciences, Inc. to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price. Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s disease and […]